Print Version
Tuberculosis Drug Information Guide
Author:
California Department of Public Health, Curry International TB Center, Curry International TB Center, California Department of Public Health, Tuberculosis Control Branch, CDHS DCDC VRDL
Publication Date:
2012
Country of Origin:
United States
Format:
Manual
Language:
English
How to Access this Material:
HTML: http://www.currytbcenter.ucsf.edu/products/view/tuberculosis-drug-information-guide-2nd-edition-printed-book
HTML: http://www.currytbcenter.ucsf.edu/products/view/tuberculosis-drug-information-guide-2nd-edition-printed-book
Abstract
The Tuberculosis Drug Information Guide, 2nd edition, is derived from Drug-Resistant Tuberculosis: A Survival Guide for Clinicians (2nd edition) produced in 2008. Two additional drugs, ofloxacin and clarithromycin (which are used primarily outside of the US), have been included. This Guide can help any physician, nurse, or pharmacist who participates in the management of patients with TB or LTBI.Publisher:
Curry International TB Center
Audience(s):
Health Professionals
Topic:
Treatment- Adverse Reactions, Treatment - Latent TB infection (Inactive TB), Treatment- TB Disease, TB Treatment, Treatment- Medication Information
Disclaimer: The information on the Find TB Resources Website is made available as a public service. Neither the Centers for Disease Control and Prevention nor the National Prevention Information Network endorses the organizations, Website s, and materials presented. It is the responsibility of the user to evaluate this information prior to use based on individual, community, and organizational needs and standards.